This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Murphy, J A Articles by Zwischenberger, J B Search for Related Content PubMed PubMed Citation Articles by Murphy, J A Articles by Zwischenberger, J B Social Bookmarking                   What's this?

Low-dose versus high-dose heparinization during arteriovenous carbon dioxide removal

Department of Surgery, The University of Texas Medical Branch, Galveston

C M Savage

Department of Surgery, University of Texas Southwestern, Dallas

S K Alpard

Department of Surgery, The University of Texas Medical Branch, Galveston

D J Deyo

Department of Anesthesiology, The University of Texas Medical Branch, Galveston, Texas

J B Jayroe

Department of Surgery, The University of Texas Medical Branch, Galveston, Texas

J B Zwischenberger

Department of Surgery, The University of Texas Medical Branch, Galveston, Texas, jzwische{at}utmb.edu

The purpose of this study was to compare low-dose (LD) and high-dose (HD) systemic heparinization in a prospective randomized study of arteriovenous carbon dioxide removal (AVCO₂R) during acute respiratory distress syndrome, using a commercially available heparin-coated oxygenator. Adult sheep (n = 13) received an LD₅₀ smoke inhalation and 40% TBSA third degree cutaneous flame burn injury. At 40-48 h post-injury, animals underwent cannulation of the carotid artery and jugular vein and were then randomized to HD heparin (activated clotting time, ACT > 300 s, n = 6) and LD heparin (ACT > 200 s, n = 7) and placed on AVCO₂R for approximately 72 h using an oxygenator with the Trillium Bio-Passive Surface^TM. Mean ACTs were significantly different, as expected (HD: 446 ± 26 s, LD: 213 ± 12 s, p < 0.05). AVCO₂R shunt flow averaged approximately 13% of cardiac output with mean CO₂ removal similar in HD and LD, p = NS. The hematocrit, platelet count, and fibrin degradation products for the two groups were not different. No differences in thrombosis or bleeding were noted. In conclusion, LD systemic heparin (ACT < 200 s) with a heparin-coated oxygenator does not increase thrombogenicity during AVCO₂R for smoke/burn-induced severe lung injury in sheep.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. Rauova, L. Zhai, M. A. Kowalska, G. M. Arepally, D. B. Cines, and M. Poncz Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications Blood, March 15, 2006; 107(6): 2346 - 2353. [Abstract] [Full Text] [PDF]

				X. Zhou, D. B Loran, D. Wang, B. R Hyde, S. D Lick, and J. B Zwischenberger Seventy-two hour gas exchange performance and hemodynamic properties of NOVALUNG(R)iLA as a gas exchanger for arteriovenous carbon dioxide removal Perfusion, December 1, 2005; 20(6): 303 - 308. [Abstract] [PDF]